Search

everythinglearnresearchcommunity

for

Search:↓

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Using 10% topical minoxidil, oral finasteride, and microneedling together can effectively treat Male Pattern Baldness with high patient satisfaction and no major side effects.

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Trichoscopy helps diagnose and monitor hair loss, showing different signs at various stages of hair thinning.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

CHOP chemotherapy causes many side effects but is generally well tolerated.

Baricitinib is effective and safe for treating severe alopecia areata.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Tempol is safe and may prevent hair loss from brain radiotherapy.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Platelet Rich Plasma (PRP) injections can effectively reduce hair loss and improve hair growth in both men and women suffering from androgenic alopecia.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

PRP with microneedling is more effective than PRP alone for treating hair loss.

Korean medicine may help with hair growth in alopecia, but more research is needed to confirm this.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

PRP therapy for hair loss is safe but its effectiveness is doubtful.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Finasteride doesn't negatively affect sexual function in Indian men with hair loss.

Female hair loss patients more likely to have dry eye and gland issues.